Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

This study is collecting information from men with advanced prostate cancer, meaning the cancer may have spread from where it started. Researchers are not testing a new treatment, but rather gathering biological samples (like blood and urine) and health details (such as treatments, diet, and quality of life) over up to five years. The goal is to build a resource for future research to better understand prostate cancer and find ways to improve patient outcomes. You can join if you are a man aged 18 or older with advanced prostate cancer who is about to start a new treatment. The current recruitment status is unclear.

Study design
This is an observational study aiming to enroll 300 participants. It involves collecting information and samples without testing a specific intervention.
What's involved
You would provide blood and urine samples, complete surveys, and have your medical records reviewed. This will occur over a period of up to 5 years.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for up to 5 years to collect biological specimens and clinical data.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06067295

Longitudinal Advanced Prostate Cancer Cohort (LAPCC)

Recruiting
Not specifiedAges 18+Observational
University of Southern California
~300 participants
Updated 2026-03-10 on ClinicalTrials.gov
What's tested:Non-Interventional Study

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Collection of biological specimens and clinical data for future research related to prostate cancer.
Measured over Up to 5 years
Prostate Carcinoma
2 sites across 1 states
California2
  • Amir Goldkorn, MD · PRINCIPAL_INVESTIGATOR · University of Southern California

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Men of all racial and ethnic groups 18 years of age or older
Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
Prior participation on clinical trials is allowed

Exclusion

Inability to give informed consent
Any other malignancy, unless previously treated with curative intent and the subject has been disease free for 3 years or longer
  • Collection of biological specimens and clinical data for future research related to prostate cancer.Up to 5 years

    The objective of this study is to create a biorepository of biospecimen and clinical data. There is no primary clinical outcome for this study.